Company dynamics
In October 2026, Garden Bio, Minsheng Healt, Nengter Technology disclosed their Q3 reports for 2026.
On 7 October, 2026, Garden Bio announced that it had recently signed the Cooperation Agreement for the Development of 25-hydroxycholesterol New Drugs with Guangzhou National Laboratory.
Project progress
On 29 September, 2026, the EI report for Tianxin Pharma's 7,000 t/a alanine expansion project was announced to be approved.
On 9 October, 2026, the EI report for Jilin Beisha's technical renovation project was publicised.
On 12 October, 2026, the EI report for Lier Biotech's bio-fermented technology industry construction project (Phase II modification) was publicised.
On 9 October, 2026, Brother Vitamins' 3,200 t/a vitamin B1 project (Phase I) passed acceptance check.
The USD/RMB exchange rate in this Report is USD1.00=CNY6.7367 on 8 October, 2026, sourced from the People's Bank of China. All the prices mentioned in this report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
